Bliss GVS Pharma Ltd consolidated Q1FY25 profit up at Rs. 20.69 crores

Bliss GVS Pharma Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 187.7654 crores during the period ended June 30, 2024 as compared to Rs. 203.7278 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 20.6974 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. -9.1477 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 1.93 for the period ended June 30, 2024 as compared to Rs. -0.86 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 187.7654 crs	₹203.7278 crs	-7.84%
Net Profit	₹20.6974 crs	₹-9.1477 crs	326.26%
EPS	₹1.93	₹-0.86	324.42%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 187.7654 crores during the period ended June 30, 2024 as compared to Rs.164.6344 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.20.6974 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.14.6851 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.1.93 for the period ended June 30, 2024 as compared to Rs.1.38 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 187.7654 crs	₹164.6344 crs	14.05%
Net Profit	₹20.6974 crs	₹14.6851 crs	40.94%
EPS	₹1.93	₹1.38	39.86%

Shares of Bliss GVS Pharma Limited was last trading in BSE at Rs. 112.15 as compared to the previous close of Rs. 108.90. The total number of shares traded during the day was 40738 in over 723 trades.

The stock hit an intraday high of Rs. 114.25 and intraday low of 107.75. The net turnover during the day was Rs. 4515237.00.

Source : Equity Bulls

Keywords

BlissGVSPharma Q1FY25 FY2025 Q1FY2025 ResultUpdate